2026 NPPES data Dermatology Physician NPI 1326057449 MD
Verify on CMS →

RASHEL GOODKIN, MD

Dermatology Physician in WELLESLEY, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
989
Medicare Part D claims · 355 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$177.4
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RASHEL GOODKIN, MD filed 989 Medicare Part D claims in 2023 as a Dermatology Physician in WELLESLEY, Massachusetts, prescribing 87% generic.

989
Part D claims, 2023
87%
generic prescribing
$177.4
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RASHEL GOODKIN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

989 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

RASHEL GOODKIN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RASHEL GOODKIN, MD?

Quality data not reported

NPI registry status

Active

Issued 08/07/2006

NPI 1326057449

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

989 36% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Massachusetts

How Dermatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Dermatology Physician share within Massachusetts

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RASHEL GOODKIN, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 10 LAUREL AVE, WELLESLEY, MA, 02481, with a listed phone of (781) 235-8155. NPI 1326057449 was issued on 08/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GOODKIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 989 prescription claims written by this provider, covering 355 Medicare beneficiaries and totaling roughly $311K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10 LAUREL AVE
WELLESLEY, MA 02481

Provider Details

NPI 1326057449
Specialty Dermatology Physician
Credentials MD
Gender Female
NPI Issued 08/07/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RASHEL GOODKIN, MD. Source: openpaymentsdata.cms.gov.

Total received

$177

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to RASHEL GOODKIN, MD. To verify RASHEL GOODKIN, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

RASHEL GOODKIN, MD — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 989 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

989
Total Claims
$311K
Total Drug Cost
355
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,150
Total Day Supply
30,325
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$272K
Generic Drug Cost
$39K
Antibiotic Claims
18

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
0.98
Gender Split
61% female / 39% male
Age Distribution
<65: 16, 65-74: 157, 75-84: 132, 85+: 50

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RASHEL GOODKIN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
251
Triamcinolone Acetonide
100
Betamethasone Valerate
84
Tacrolimus
70
Fluorouracil
65
Halobetasol Propionate
55
Clindamycin Phosphate
52
Clobetasol Propionate
47
Jublia
Efinaconazole
38
Calcipotriene
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How RASHEL GOODKIN, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

RASHEL GOODKIN, MD's 989 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as GOODKIN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RASHEL GOODKIN, MD's specialty?
RASHEL GOODKIN, MD specializes in Dermatology Physician and practices in WELLESLEY, Massachusetts. Credentials: MD.
How much does RASHEL GOODKIN, MD prescribe under Medicare Part D?
In 2023, RASHEL GOODKIN, MD wrote 989 Medicare Part D claims totaling $311K in drug costs for 355 beneficiaries.
Where is RASHEL GOODKIN, MD located?
RASHEL GOODKIN, MD is located at 10 LAUREL AVE, WELLESLEY, MA, 02481. Phone: (781) 235-8155.
What is RASHEL GOODKIN, MD's NPI number?
RASHEL GOODKIN, MD's National Provider Identifier (NPI) is 1326057449, issued on 08/07/2006.
Does RASHEL GOODKIN, MD prescribe more brand-name or generic drugs?
RASHEL GOODKIN, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $272K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does RASHEL GOODKIN, MD prescribe most often?
Based on 2023 Medicare Part D data, RASHEL GOODKIN, MD's most frequently prescribed drugs include Ketoconazole, Triamcinolone Acetonide, Betamethasone Valerate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RASHEL GOODKIN, MD accept Medicare?
RASHEL GOODKIN, MD appears in CMS Medicare data with 989 Part D claims and 355 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RASHEL GOODKIN, MD's credentials?
RASHEL GOODKIN, MD's NPI is 1326057449 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology